PLK
PLK (Polo-like kinase 1) is a serine/threonine-protein that are implicated in cell cycle, mitosis, cytokinesis and DNA damage etc.
Products Related to PLK(51)
- GC12515NMS-1286937CAS: 1034616-18-6Purity: >98.00%
NMS-1286937 is an orally active small-molecule compound. NMS-1286937 potently and selectively inhibits Polo-like kinase 1 (PLK1) activity with a half-maximal inhibitory concentration (IC 50 ) of 2nM.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC13580 | Rigosertib sodium | 592542-60-4 | >98.50% | |
Non-ATP-competitive inhibitor of PLK1 | ||||
| GC12515 | NMS-1286937 | 1034616-18-6 | >98.00% | |
NMS-1286937 is an orally active small-molecule compound. NMS-1286937 potently and selectively inhibits Polo-like kinase 1 (PLK1) activity with a half-maximal inhibitory concentration (IC 50 ) of 2nM. | ||||
| GC14735 | Poloxime | 17302-61-3 | >98.00% | |
polo-like kinase 1 (PLK) analogue | ||||
